Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 99,919 |
| Other current assets | 6,230 |
| TOTAL | $106,149 |
| Non-Current Assets | |
| PPE Net | 22,100 |
| TOTAL | $22,100 |
| Total Assets | $149,957 |
| Liabilities | |
| Current Liabilities | |
| TOTAL | $20,783 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 383,902 |
| TOTAL | $383,902 |
| Total Liabilities | $432,416 |
| Shareholders' Equity | |
| Retained earnings | -295,271 |
| Other shareholders' equity | 12,812 |
| TOTAL | $-282,459 |
| Total Liabilities And Equity | $149,957 |